Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Myeloma
Closed
Phase 2
This trial is looking at a drug called pomalidomide with a low dose of the steroid dexamethasone for myeloma that is not responding to treatment or has come back. The people taking part have myeloma and their kidneys are not working very well.
Recruitment start: 1 May 2014
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr M Streetly
Celgene Corporation
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 28 Jul 2016
CRUK internal database number: 12220